Financial Year |
March 31 2023 |
Monetary Funds |
9,260,113,000.00 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
89,453,000.00 |
Accounts Receivable |
18,578,716,000.00 |
Advances to Suppliers |
6,055,789,000.00 |
Other Receivables |
2,533,457,000.00 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
87,560,000.00 |
Dividend Receivable |
1,352,811,000.00 |
Inventories |
4,280,015,000.00 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
1,341,000.00 |
Other Current Assets |
2,658,827,000.00 |
Total Current Assets |
43,817,199,000.00 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
59,748,000.00 |
Long-term Equity Investment |
20,173,187,000.00 |
Investment Properties |
488,423,000.00 |
Fixed Assetes |
189,265,008,000.00 |
Under-construction Projects |
23,773,810,000.00 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
4,426,179,000.00 |
R&D expenses |
256,505,000.00 |
Goodwill |
762,979,000.00 |
Long-Term Deferred and Prepaid Expenses |
575,669,000.00 |
Deferred Income Tax Assets |
4,379,131,000.00 |
Other Non-Current Assets |
7,459,483,000.00 |
Sub-Total of Non-Current Assets |
260,300,360,000.00 |
Total Assets |
304,117,559,000.00 |
Short-Term Loans |
35,157,262,000.00 |
Trading Financial liabilities |
-- |
Notes Payable |
1,498,639,000.00 |
Accounts Payable |
25,455,222,000.00 |
Accounts Received In Advance |
2,172,000.00 |
Employee Compensation Payable |
171,982,000.00 |
Taxes Payable |
1,182,113,000.00 |
Interest Payable |
-- |
Dividend Payable |
480,401,000.00 |
Other payables |
4,509,304,000.00 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
16,083,102,000.00 |
Other Current Liabilities |
324,789,000.00 |
Sub-Total of Current Liabilities |
84,885,832,000.00 |
Long-term Loans |
114,413,677,000.00 |
Bonds Payable |
6,485,160,000.00 |
Long-Term Accounts Payable |
6,600,451,000.00 |
Special Payable |
-- |
Estimatied Liabilities |
9,015,000.00 |
Deferred Income Tax Liabilities |
739,698,000.00 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
131,536,654,000.00 |
Total Liabilities |
216,422,486,000.00 |
Paid-In Capital(Or Share Stock) |
18,506,711,000.00 |
Capital Surplus |
6,155,609,000.00 |
Surplus Reserve |
16,043,234,000.00 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
-13,160,117,000.00 |
Minority Stockholder's Interest |
13,522,144,000.00 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
74,172,929,000.00 |
Owner's Equity(Stockholder's Equity) |
87,695,073,000.00 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
304,117,559,000.00 |